Clinical Trial Update: To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA) [NA]

View source ↗

Summary

This clinical trial update outlines an evaluation of Nisha-Amalaki tablets as an add-on to insulin to improve glycemic control in Type 1 diabetes. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Nisha-Amalaki tablets

Snippet

Sponsor: Hirabai Cowasji Jehangir Medical Research Institute | Conditions: Type 1 Diabetes | NA | Status: ACTIVE_NOT_RECRUITING